4 Phases of IV Fluid Therapy Final
4 Phases of IV Fluid Therapy Final
4 Phases of IV Fluid Therapy Final
Therapy
DR CHARLIE
Introduction
IV fluid therapy plays a fundamental role in management of
hospitalised patients.
Correct usage can be life saving, but with risks.
Inappropriate usage of fluids occur in up to 20% of patient receiving
fluid therapy
Too little? (inadequate resuscitation, tissue hypoperfusion)
Too much? (tissue edema and severe electrolyte derangements)
Coagulation Abnormalities
Fluid therapy should be regarded as drug therapy with dose-effect
relationship and side effects, individualised to each patient.
6S Study
Higher mortality and incidence of AKI in patients receiving HES
compared with carrier solution of Ringer’s acetate.
SAFE study
Higher mortality in patients with traumatic brain injury treated with
albumin solution
R
escue
O ptimisation
S tabilisation
D eescalation
Optimisation
In COMPENSATED shock
Fluid therapy to be given cautiously
Aim: Optimise cardiac function to improve tissue perfusion.
Mitigate organ dysfunction.
Fluid CHALLENGE
Stabilisation
ABSENCE of Shock
Steady stat: maintenance or ongoing loss of
fluid.
De-escalation
• Fluid REMOVED from patient
• Promote NEGATIVE balance
Monitoring and reassessment
Individualised to each patient.
In Rescue phase,
combine clinical and haemodynamic parameters with
near patient diagnostics.
No need for sophisticated assessment like ECHO.
Reassessment and re-challenge without leaving the
bedside and continuous observation.
ECHO/Doppler, CVP, SCVO2 can be used to determine
appropriate time to transition to Optimisation phase.
In Optimisation phase,
Ensuring adequate blood and O2 delivery to at-risk organs.
Aim to prevent subsequent organ dysfunction and failure
caused by hypoperfusion and tissue oedema.